MIRM - Mirum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MIRM is currently covered by 14 analysts with an average price target of $141.8. This is a potential upside of $58.7 (70.64%) from yesterday's end of day stock price of $83.1.

Mirum Pharmaceuticals's activity chart (see below) currently has 242 price targets and 216 ratings on display. The stock rating distribution of MIRM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.95% with an average time for these price targets to be met of 388.97 days.

Highest price target for MIRM is $200, Lowest price target is $110, average price target is $141.8.

Most recent stock forecast was given by JOSEPH THOME from TD COWEN. First documented stock forecast 12-Aug-2019.

Best performing analysts who are covering MIRM - Mirum Pharmaceuticals:

Yasmeen Rahimi Steven Seedhouse Ed Arce Jonathan Wolleben Gavin Clark-Gartner Joseph Thome

Currently out of the existing stock ratings of MIRM, 57 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Sep-2025

$145

$61.56 (73.78%)

$140

Buy Since 11-Aug-2025

$156

$72.56 (86.96%)

$130

8 days ago
(15-Oct-2026)

3/5 (60%)

$73.61 (89.34%)

89

Buy Since 02-Jun-2026

$184

$100.56 (120.52%)

$160

11 days ago
(12-Oct-2026)

0/3 (0%)

$97.99 (113.93%)

Buy Since 19-May-2025

$200

$116.56 (139.69%)

$195

11 days ago
(12-Oct-2026)

4/11 (36.36%)

$113.99 (132.53%)

75

Buy Since 07-May-2026

$155

$71.56 (85.76%)

$135

15 days ago
(08-Oct-2026)

0/4 (0%)

$73.65 (90.53%)

Show more analysts

Please expand the browser size to see the chart

What is MIRM (Mirum Pharmaceuticals) average time for price targets to be met?

On average it took 389 days for the stock forecasts to be reached, with an average price target met ratio of 73.95%.

Which analyst most recently updated their price target on MIRM (Mirum Pharmaceuticals)?

Joseph Thome

Which analyst has the most public recommendations on MIRM (Mirum Pharmaceuticals)?

Joseph Thome works at TD COWEN and has 23 price targets and 14 ratings on MIRM

Which analyst is the currently most bullish on MIRM (Mirum Pharmaceuticals)?

Swayampakula Ramakanth with the highest potential upside of $116.56

Which analyst is the currently most reserved on MIRM (Mirum Pharmaceuticals)?

Joe Ritchie with the lowest potential downside of -$83.2
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?